This brings an end to a whiplash saga for Jounce, which was set to join Redx until Concentra ultimately swooped in to purchase the embattled clinical-stage firm.
Bankruptcy awaits Infinity Pharmaceuticals if MEI merger falters
Concentra’s bid also comes three weeks after Jounce and Redx Pharma unveiled a unanimously recommended business combination via a proposed all-share merger transaction.
Biotech companies sprint to clarify relationships with SVB amid bank crisis